<DOC>
	<DOCNO>NCT02660814</DOCNO>
	<brief_summary>The objective case-control intervention study , therefore , explore effect nonsurgical periodontal therapy GCF level chemerin IL-6 patient chronic periodontitis order determine usefulness chemerin diagnostic prognostic biomarker periodontal disease .</brief_summary>
	<brief_title>Chemerin Interleukin-6 Levels Gingival Crevicular Fluid Obese Individuals Following Periodontal Treatment</brief_title>
	<detailed_description>All individual underwent full-mouth periodontal examination , include probe pocket depth ( PPD ) , clinical attachment level ( CAL ) , plaque index ( PI ) , gingival index ( GI ) , bleed probe ( BOP ) . BMI WHR use assess obesity . In addition , HbA1c fast plasma glucose level use elimination diabetes mellitus . Based periodontal anthropometric measurement , individual ( n=72 ) divide four group : periodontal-healthy group ( n=18 ) , chronic periodontitis group ( n=18 ) , periodontal-healthy obesity group ( n=18 ) chronic periodontitis obesity group ( n=18 ) . Periodontitis patient receive nonsurgical periodontal therapy . GCF sample clinical periodontal parameter assess 6 week therapy . Chemerin IL-6 level measure enzyme-linked immunosorbent assay .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<criteria>1 . 3253 year age 2. minimum 20 natural teeth , exclude third molar 3 ) glycosylated hemoglobi level &lt; 6 % 4 ) fast plasma glucose level &lt; 100 mg/dl . 5 ) Criteria periodontal healthy group GI = 0 , PPD≤ 3 mm , sign attachment bone loss clinical radiographic examination . 6 ) Criteria chronic periodontitis group clinical sign inflammation ( red color swell gingival margin ) , GI ≥ 2 , PPD CAL ≥ 5 mm , bone loss affect &gt; 30 % exist teeth clinical radiographic examination . 7 ) Criteria obese group 30≤ BMI &lt; 40 kg/m2 , concomitant WHR ≥0.85 females WHR ≥0.90 male . 8 ) Criteria normalweight group 20≤ BMI &lt; 25 kg/m2 , WHR determine obesity . 1 . Aggressive periodontitis 2 . Periapical pathology 3 . Excessive force include mechanical force orthodontics occlusion 4 . Systemic disease ( e.g. , diabetes mellitus ; cancer ; human immunodeficiency virus ; disorder could affect adipokines level periodontal condition ) 5 . Chronic highdose steroid therapy , radiation immunosuppressive therapy 6 . Pregnancy , lactation 7 . Smoking within past five year , allergy sensitivity drug 8 . Had history periodontal therapy drug therapy ( e.g. , antiinflammatories , antibiotic , pharmacological treatment ) least six month</criteria>
	<gender>All</gender>
	<minimum_age>32 Years</minimum_age>
	<maximum_age>53 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chemerin</keyword>
	<keyword>Interleukin-6</keyword>
	<keyword>Gingival crevicular fluid</keyword>
</DOC>